FRESENIUS HEMOCARE BRASIL LTDA.
- Shared products
- ANTI-HUMAN GLOBULIN (COOMBS), COMBINED PARAMETERS IN THE SAME PRODUCT - CLASS IV, IMMUNOHEMATOLOGY - ABO - MONOCLONAL ORIGIN, IMMUNOHEMATOLOGY - LECTINS, IMMUNOHEMATOLOGY - RARE SERA FOR CONVENTIONAL METHODOLOGY, IMMUNOHEMATOLOGY - RED BLOOD CELL REAGENTS/ENZYME-TREATED RED BLOOD CELL REAGENTS, IMMUNOHEMATOLOGY - RH-HR, KELL, KIDD, DUFFY - MONOCLONAL ORIGIN
- Shared products
- ANTI-HUMAN GLOBULIN (COOMBS), COMBINED PARAMETERS IN THE SAME PRODUCT - CLASS IV, IMMUNOHEMATOLOGY - ABO - MONOCLONAL ORIGIN, IMMUNOHEMATOLOGY - COMPLEMENTARY REAGENTS, IMMUNOHEMATOLOGY - RED BLOOD CELL REAGENTS/ENZYME-TREATED RED BLOOD CELL REAGENTS, IMMUNOHEMATOLOGY - RH-HR, KELL, KIDD, DUFFY - MONOCLONAL ORIGIN
- Shared products
- ANTI-HUMAN GLOBULIN (COOMBS), IMMUNOHEMATOLOGY - ABO - MONOCLONAL ORIGIN, IMMUNOHEMATOLOGY - COMPLEMENTARY REAGENTS, IMMUNOHEMATOLOGY - LECTINS, IMMUNOHEMATOLOGY - RARE SERA FOR CONVENTIONAL METHODOLOGY, IMMUNOHEMATOLOGY - RH-HR, KELL, KIDD, DUFFY - MONOCLONAL ORIGIN
- Shared products
- ANTI-HUMAN GLOBULIN (COOMBS), IMMUNOHEMATOLOGY - ABO - MONOCLONAL ORIGIN, IMMUNOHEMATOLOGY - COMPLEMENTARY REAGENTS, IMMUNOHEMATOLOGY - RARE SERA FOR CONVENTIONAL METHODOLOGY, IMMUNOHEMATOLOGY - RH-HR, KELL, KIDD, DUFFY - MONOCLONAL ORIGIN
- Shared products
- ANTI-HUMAN GLOBULIN (COOMBS), COMBINED PARAMETERS IN THE SAME PRODUCT - CLASS IV, IMMUNOHEMATOLOGY - ABO - MONOCLONAL ORIGIN, IMMUNOHEMATOLOGY - COMPLEMENTARY REAGENTS, IMMUNOHEMATOLOGY - RH-HR, KELL, KIDD, DUFFY - MONOCLONAL ORIGIN
Explore comprehensive manufacturer profile for FRESENIUS HEMOCARE BRASIL LTDA. based in Brazil through Pure Global AI's free Brazil medical device database. This manufacturer has 26 products registered with ANVISA across 14 unique technical categories. Their regulatory history spans from Jul 18, 1996 to Jun 13, 2022.
This page provides detailed insights including 5 recent product registrations including Leukocyte Removal Filter (Transfusion), 5 most popular products with Blood Bags having 6 registrations, 1 registration holders including FRESENIUS HEMOCARE BRASIL LTDA., and 5 key competitors with MEDION GRIFOLS DIAGNOSTICS AG sharing 7 products. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, enabling global MedTech companies to analyze market dynamics and identify opportunities.